SciELO - Scientific Electronic Library Online

 
vol.13 issue4Efectos adversos de consecuencia fatal por tratamiento con fármacos antituberculosos author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO

Share


Revista Medica Herediana

Print version ISSN 1018-130XOn-line version ISSN 1729-214X

Abstract

MAGUINA VARGAS, Ciro  and  SOLARI ZERPA, Lesly. New and older quinolones. Rev Med Hered [online]. 2002, vol.13, n.4, pp.153-160. ISSN 1018-130X.

Quinolones are a family of antibiotics of great importance in the management of several community and nosocomial diseases. Therefore, it is important to know the qualities of the old and new quinolones. Quinolones, as anti-infectious agents, are effective and safe and few times occurs adverse events. After 1962, when the first quinolon, nalidix acid, appeared, new generations of quinolones (fourth generation) have appeared in the market. However, we should know strictly its indications, most infectious diseases are the agents of elections, but in another cases, are drugs of second line. The objective of this review is to know better all quinolones in order to avoid the appearance of resistance due to its mal practice. In this review, we present pharmakocinetic aspects, currently indications of the fluorquinolones, the importance of new quinolones, the mechanisms of resistance, its contraindications and adverse events. (Rev Med Hered 2002; 13:153-160).

Keywords : Quinolones; fluoroquinolones; new quinolones.

        · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License